Sab Biotherapeutics, Inc. · NASDAQ:SABS

Perceptive Advisors LLC reported a 8.40% stake in Sab Biotherapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Perceptive Advisors LLC reported a 8.40% stake in Sab Biotherapeutics, Inc., 6,431,743 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
8.40%
Shares
6,431,743
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC8.40%6,431,743
Joseph Edelman8.40%6,431,743
Perceptive Life Sciences Master Fund, Ltd.8.40%6,431,743

Source

View original at SEC

Related